 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
Clearview H. Pylori Test
Clearview H. pylori uses rapid, two-step technology for the direct detection of Helicobacter pylori antibodies. Reduce the risk of gastric cancer with the fast, accurate and early diagnosis of H. pylori infection
-
The vast majority of gastric infections are asymptomatic
-
Clinical trials have shown that H. pylori is associated with 98% of patients with duodenal ulcer and around 80% of those with gastric ulcer
-
Infected H. pylori patients have a 2-6 fold increased risk of developing gastric cancer -
One fifth of cancers worldwide are due to chronic infections, including H. pylori in stomach cancers
Clearly Different
The patented, innovative technology used by Clearview H. pylori provides highly sensitive and specific detection of H. pylori.
-
Fast: two-step test provides results in 10 minutes
-
Easy: simple procedure; CLIA-waived for whole blood
-
Reliable: built-in procedural control
-
Flexible: use with multiple sample types -- whole blood, serum or plasma
Features and Benefits
Features |
Benefits |
Results in 10 minutes |
Rapid |
Inbuilt procedural control |
Reliable |
Can be used with Serum, plasma or whole blood (venous and fingerprick) |
Flexible |
Easy-to-use and to interpret result |
Minimal training required |
Room temperature storage |
Ready to use, leaves valuable refrigerator space free |
Long shelf life |
Small volume users need not worry that product will expire before used |